Chamath Pal­i­hapi­tiya, the out­spo­ken 'K­ing of SPACs,' turns his eyes to biotech with plans to cash an $800M blank check

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

He’s been called the “SPAC King” and the “Pied Piper of SPACs.” He’s a co-own­er of the NBA’s Gold­en State War­riors. He has over 1.5 mil­lion fol­low­ers on Twit­ter, and was an ear­ly ex­ec­u­tive at Face­book.

Now, Chamath Pal­i­hapi­tiya is turn­ing his at­ten­tion to biotech with a laser fo­cus on the in­dus­try stand­ing out from a typ­i­cal SPAC syn­di­cate.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER